Functional effects of long‐term activation on human β2‐ and β3‐adrenoceptor signalling
Open Access
- 1 March 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (5) , 1045-1051
- https://doi.org/10.1111/j.1476-5381.1995.tb13311.x
Abstract
The functional effects of long‐term activation of β‐adrenoceptors were investigated by measuring adenylyl cyclase activity, cyclic AMP accumulation and cyclic AMP‐dependent protein kinase activity in CHW and L cells expressing either human β2‐ or β3‐adrenoceptors. Pre‐incubation of CHW and L cells expressing β2‐adrenoceptors with 10 μm isoprenaline for 24 h produced a marked reduction in the total receptor number and dramatically reduced the capacity of the receptor to stimulate adenylyl cyclase maximally. In contrast, the ability of β3‐adrenoceptors to stimulate adenylyl cyclase maximally was not affected by pre‐incubation with the agonist in either cell type. However, a significant reduction of isoprenaline potency and a sustained down‐regulation of β3‐adrenoceptor number was observed in L but not in CHW cells. Maximal levels of intracellular cyclic AMP concentrations were reached during the first hour of receptor activation with isoprenaline in all four cell lines. In the absence of phosphodiesterase inhibitors, cyclic AMP decreased to basal levels within 24 h of continuous stimulation. This phenomenon occurred more rapidly in cells expressing the β2‐ than the β3‐adrenoceptors. These results confirm that, at the level of adenylyl cyclase stimulation and cyclic AMP accumulation, the β3‐adrenoceptor is more resistant than the β3‐adrenoceptor to long‐term desensitization. However, when cyclic AMP‐dependent protein kinase activity was considered, a 24 h stimulation of β2‐ and β3‐adrenoceptor expressing cells led to the desensitization of the kinase in L but not in CHW cells. In conclusion, long‐term desensitization may have distinct functional effects on cell signalling depending on the receptor subtype and the cell type considered. These findings might have practical implications for future strategies involving long‐term therapies with receptor agonists.Keywords
This publication has 31 references indexed in Scilit:
- β3 and Atypical β‐AdrenoceptorsMedicinal Research Reviews, 1993
- G protein—coupled receptor kinasesCell, 1993
- Tissue distribution of beta 3-adrenergic receptor mRNA in man.Journal of Clinical Investigation, 1993
- Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in AsthmaNew England Journal of Medicine, 1992
- Autoantibodies To The Tsh Receptor In Patients With Autoimmune Thyroid DiseaseClinical Endocrinology, 1990
- Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical adrenoceptor agonistBMJ, 1988
- β adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulationJournal of Cellular Physiology, 1984
- Pheochromocytoma: Diagnosis, Localization and ManagementNew England Journal of Medicine, 1984
- Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic TherapyNew England Journal of Medicine, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976